According to PetIQ's latest financial reports the company has NZ$0.14 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | NZ$0.18 B | 15.37% |
2022-12-31 | NZ$0.15 B | 37.2% |
2021-12-31 | NZ$0.11 B | 150.72% |
2020-12-31 | NZ$46.36 M | 14.5% |
2019-12-31 | NZ$40.49 M | -59.07% |
2018-12-31 | NZ$98.93 M | 85.4% |
2017-12-31 | NZ$53.35 M | 4718.97% |
2016-12-31 | NZ$1.1 M | -76.68% |
2015-12-31 | NZ$4.74 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | NZ$27.44 M | -80.52% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | NZ$0.73 B | 418.24% | ๐บ๐ธ USA |